Obinutuzumab Alone or Combined with Chemotherapy in Previously Untreated (Fit or Unfit) or Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) Patients: Final Results from the Phase IIIb GREEN Safety Study with a Focus on Efficacy

Stephan S., Bosch F., Vronique L., İLHAN O., Jens K., Batrice M., ...Daha Fazla

ASH 2019, 7 - 10 Aralık 2019

  • Yayın Türü: Bildiri / Tam Metin Bildiri
  • Lokman Hekim Üniversitesi Adresli: Evet